ATOMMAP
Live / Applied — Statement of use — registration review complete (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 19 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98367135
- Mark type
- Stylized text
- Filed
- 19 Jan 2024
- Published for opposition
- 17 Sept 2024
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of computational biology, bioinformatics, and genomics; Drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; provision of online non-downloadable software for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products
Owner
- Atommap Corporation, New York, NY, US
- Atommap Corporation, Washington, DC, US
Prosecution history
- 30 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 29 May 2025 — USE AMENDMENT FILED
- 12 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2025 — SOU EXTENSION 1 GRANTED
- 08 May 2025 — SOU EXTENSION 1 FILED
- 07 May 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER